Israel - English - Ministry of Health

abic marketing ltd, israel - quetiapine as fumarate - film coated tablets - quetiapine as fumarate 200 mg - quetiapine - quetiapine - ttreatment of schizophrenia. treatment of manic episodes associated with bipolar disorder.treatment of major depressive episodes in bipolar disorders.

Israel - English - Ministry of Health

abic marketing ltd, israel - quetiapine as fumarate - film coated tablets - quetiapine as fumarate 300 mg - quetiapine - quetiapine - ttreatment of schizophrenia. treatment of manic episodes associated with bipolar disorder.treatment of major depressive episodes in bipolar disorders.

Israel - English - Ministry of Health

inovamed ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 50 mg - quetiapine - quetiapine inovamed sr is indicated for the treatment of schizophrenia. quetiapine inovamed sr is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine inovamed sr. quetiapine inovamed sr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. quetiapine inovamed sr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy. prior to initiating treatment, clinicians should consider the safety profile of quetiapine inovamed sr.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 150 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 200 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 300 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 400 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 50 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - quetiapine fumarate, quantity: 57.565 mg (equivalent: quetiapine, qty 50 mg) - tablet, modified release - excipient ingredients: lactose monohydrate; iron oxide yellow; titanium dioxide; macrogol 400; povidone; light magnesium oxide; carrageenan; microcrystalline cellulose; magnesium stearate; iron oxide red - bipolar disorder - maintenance treatment of bipolar 1 disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes. treatment of depressive episodes associated with bipolar disorder (see dosage and administration). treatment of acute mania associated with bipolar i disorder as monotherapy or incombination with lithium or sodium valproate. efficacy of quetiapine in the treatment of bipolar disorder indications was established in part, on the basis of extrapolation from the established effectiveness of quetiapine immediate release tablets. schizophrenia - treatment of schizophrenia, prevention of relapse and maintenance of clinical improvement during continuation therapy. major depressive disorder (mdd)- treatment of recurrent major depressive disorde in patients who are intolerant of, or who have an inadequate response to alternative therapies. generalised anxiety disorder (gad). treatment of generalised anxiety disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - quetiapine fumarate, quantity: 172.695 mg (equivalent: quetiapine, qty 150 mg) - tablet, modified release - excipient ingredients: titanium dioxide; magnesium stearate; microcrystalline cellulose; macrogol 400; lactose monohydrate; light magnesium oxide; carrageenan; povidone - bipolar disorder - maintenance treatment of bipolar 1 disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes. treatment of depressive episodes associated with bipolar disorder (see dosage and administration). treatment of acute mania associated with bipolar i disorder as monotherapy or incombination with lithium or sodium valproate. efficacy of quetiapine in the treatment of bipolar disorder indications was established in part, on the basis of extrapolation from the established effectiveness of quetiapine immediate release tablets. schizophrenia - treatment of schizophrenia, prevention of relapse and maintenance of clinical improvement during continuation therapy. major depressive disorder (mdd)- treatment of recurrent major depressive disorde in patients who are intolerant of, or who have an inadequate response to alternative therapies. generalised anxiety disorder (gad). treatment of generalised anxiety disorder.